QQ客服 官方微博 反馈留言

	The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent
	Zhang, Qiangbo; Wang, Hong; Ran, Lin; Zhang, Zongli; Jiang, Runde
刊名	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
	2016
卷号	476期号:4页码:260-266
关键词	Pancreatic cancer TIC10 TRAIL Gemcitabine Akt-Erk signaling Chemosensitization
DOI	10.1016/j.bbrc.2016.05.106
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4762629
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Peoples R China. 2.Weifang Med U
推荐引用方式 GB/T 7714	Zhang, Qiangbo,Wang, Hong,Ran, Lin,et al. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2016,476(4):260-266.
APA	Zhang, Qiangbo,Wang, Hong,Ran, Lin,Zhang, Zongli,&Jiang, Runde.(2016).The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,476(4),260-266.
MLA	Zhang, Qiangbo,et al."The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 476.4(2016):260-266.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。